Treatment of tropical and parasitic diseases using medicines that are not licensed in Japan

Treatment of tropical and parasitic diseases using medicines that are not licensed in Japan - Treatment of tropical and parasitic diseases using medicines that are not licensed in Japan

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004125

Enrollment

750

Registered

2010-09-01

Start date

2011-10-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tropical diseases, parasitic diseases

Interventions

When considered to be most appropriate, we administer unlicensed medicines (19 items) that our research group introduced to patients with tropical and parasitic diseases with the world-standard dosag

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with tropical and parasitic diseases for whom treatment with unlicensed medicines that our research group introduced is considered to be most appropriate

Exclusion criteria

Exclusion criteria: Patients who are allergic to the drugs, patients for whom the possible disadvantages due to the drug adverse events may overweigh the advantages due to the drug's clinical effects

Design outcomes

Primary

Measure	Time frame
Clinical effects and adverse events due to drug treatments	—

Countries

Japan

Contacts

Public ContactHaruhiko Maruyama

University of Miyazaki, Faculty of Medicine Department of Infectious Diseases

hikomaru@med.miyazaki-u.ac.jp0985-85-0990

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026